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Abstract. We describe the use of optical coherence tomography
OCT for high-resolution, real-time imaging of three-dimensional
structure and development of a Pseudomonas aeruginosa biofilm in a
standard capillary flow-cell model. As the penetration depth of OCT
can reach several millimeters in scattering samples, we are able to
observe complete biofilm development on all surfaces of a 1 mm
1 mm flow-cell. We find that biofilm growing at the bottom of the
tube has more structural features including voids, outward projec-
tions, and microcolonies while the biofilm growing on the top of the
tube is relatively flat and contains less structural features. Volume-
rendered reconstructions of cross-sectional OCT images also reveal
three-dimensional structural information. These three-dimensional
OCT images are visually similar to biofilm images obtained with con-
focal laser scanning microscopy, but are obtained at greater depths.
Based on the imaging capabilities of OCT and the biofilm imaging
data obtained, OCT has potential to be used as a non-invasive, label-
free, real-time, in-situ and/or in-vivo imaging modality for biofilm
characterization. © 2006 Society of Photo-Optical Instrumentation Engineers.
DOI: 10.1117/1.2209962
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Micro-organisms bacteria, fungi, and/or protozoa, with asso-
ciated bacteriophages and other viruses can grow collectively
in adhesive polymers mainly extracellular polysaccharides
EPS on biologic or nonbiologic surfaces to form biofilms.
Biofilms are ubiquitous in natural and industrial environ-
ments, and it is now thought that biofilms are the primary
habitat for many micro-organisms, as biofilm can protect mi-
crobes from harsh environments such as the presence of anti-
biotics and biocides.1–3 Biofilms have been associated with a
wide range of problems both in industry and medicine, as it is
very difficult to eradicate them with common practice. Ac-
cording to the National Institutes of Health, biofilms account
for more than 80% of microbial infections in the body.4 Bio-
films can virtually colonize any indwelling device catheters,
artificial joints, and contact lenses and different tissues oral
soft tissues, teeth, middle ear, gastrointestinal tract, urogenital
tract, airway/lung tissue, etc..5–8 Biofilms colonized on de-
vices are the sources of most medical device-related
infections.9 Currently, there are few, if any, effective strategies
to impede the process of biofilm colonization of these devices.
The use of a high-resolution, 3-D imaging modality offers the
potential to improve our visualization and understanding of
the complex dynamics within biofilms.
*Current affiliation: The Univ. of Michigan, School of Public Health, Dept. of
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enous distribution of cells in a uniform exopolysaccharide
matrix that lacks heterogeneity in structure.10 The application
of optical imaging techniques, especially confocal scanning
laser microscopy CSLM, radically altered the perception of
biofilm structure and function.11 Most biofilms have been
found to exhibit some level of heterogeneity in structure with
a variable distribution of cells and cellular aggregates, vari-
able density of extracellular polymers, and void spaces or
water channels.1,12 These heterogeneous features appear to be
common to most biofilms, as they were not only found in
mixed-cultured biofilms but also found in monospecies
biofilms.1,13 The biofilm structure can be affected by numer-
ous environmental parameters and may have a direct relation-
ship with biofilm function. It was suggested that the structural
diversity actually reflects the adaptation of unicellular organ-
isms to a diverse range of physical, chemical, and communal
circumstances on surfaces.1
A number of optical and nonoptical imaging techniques
have been developed previously for use in the study of biofilm
structure and development. These techniques include, but are
not limited to, light microscopy,10,14 electron microscopy,15
CSLM,11,16 infrared spectroscopy,17 reflectance
spectroscopy,16 optical fluorometry,18,19 nuclear magnetic
resonance imaging NMRI,20–24 atomic force microscopy
AFM,25 and photoacoustic spectroscopy.26 The study of bio-
films using these imaging techniques has revealed many fea-1083-3668/2006/113/034001/6/$22.00 © 2006 SPIE
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structure and function. However, there are limitations associ-
ated with each technique. For example, sample preparation for
electron microscopy will alter the original structure of bio-
films. CSLM is very widely used for biofilm research; how-
ever, cell labeling requirements limit its use for study of natu-
ral biofilm in vivo, and shallow imaging penetration limits its
application in the study of very thick biofilms. NMRI can be
used to image biofilm structure and flow profiles in biofilms;
however, low image resolution and long acquisition times for
images limit its application in biofilm monitoring in real time.
Optical coherence tomography OCT is an emerging high-
resolution medical and biological imaging technology27–31
that can perform optical ranging of biological and nonbiologi-
cal structures in a manner similar to ultrasound Fig. 1a.
Because OCT uses the shorter wavelengths of near-infrared
light rather than sound, imaging resolution can be 10 to 100
times higher. Near-infrared wavelengths are used in OCT im-
aging to increase imaging penetration through highly scatter-
ing structures. It is possible to image depths of several centi-
meters through transparent structures and of a few millimeters
in highly scattering tissue. We report the first use of OCT to
image biofilms, specifically a Pseudomonas aeruginosa bio-
film developed in a capillary flow cell, which is representative
of a wide range of scenarios where biofilms develop. This
particular bacteria species was chosen for this study, since it is
a virulent pathogen commonly found to colonize on medical
catheters, tubing, and devices in clinical settings, and its bio-
film structures developed under different conditions have been
reported previously.11,32–36 We demonstrate that OCT tech-
niques have the potential for noninvasive, label-free, real-time
and in-situ and/or in-vivo characterization of biofilm structure
Fig. 1 Experimental set-up. a Schematic diagram of the OCT imag-
ing system, and b biofilm reactor system. The cross sectional dimen-
sion of the glass flow-cell tube is 11 mm.and function.
Journal of Biomedical Optics 034001-2 Materials and Methods
2.1 Bacterial Strains, Culture Conditions, and Biofilm
Development
Pseudomonas aeruginosa PAO1 was used throughout this
study. To visualize the same biofilm growth with OCT and
CSLM, the strain PAO1 was transformed with a plasmid
pMP4655 carrying an egfp gene.37 Green fluorescent protein
GFP was expressed constitutively. Strains were routinely
cultured on Trypticase soy agar Becton Dickinson, Sparks,
MD, and when appropriate, tetracycline was added final
concentration of 20 g/ml. A dilute broth medium Trypti-
case soy broth TSB, pH 6.8 at a concentration of
3 g per liter dTSB was used for the flow system to grow
biofilms.
Biofilms were cultivated in a single-channel flow cell
11 mm, Biosurface Technologies, Bozeman, Montana
supplied with diluted TSB at a flow rate of 0.3 ml/min for
72 h using a L/V Variable Speed Digital Drive Pump system
Cole Parmer, Vernon Hills, Illinois Fig. 1b. Procedures
for growing biofilms in the flow cell were as described
previously.38,39
Pseudomonas aeruginosa PAO1 was also inoculated into
an optical polystyrene OPS cuvette 101045 mm,
VWR, Batavia, Illinois filled with one third of volume of
TSB and incubated at 30 °C with shaking at 100 rpm for
72 h. Biofilms developed on the inner wall of the cuvette, and
the interface of air and media were imaged with OCT.
2.2 Optical Coherence Tomography
The OCT system consisted of galvanometer-scanned mirrors
for the delay mechanism and the transverse scanning. The
optical source was a mode-locked Ti-sapphire laser Kapteyn-
Murnane Laboratories, Incorporated, Boulder, Colorado cen-
tered at 800 nm with an output of approximately 100-nm
bandwidth 2.8-m axial resolution. The 1.3-mm-diameter
beam was incident on the back aperture of a 20-mm focal
length achromatic lens, giving a free-space numerical aperture
of 0.065. The light was focused to a 15-m spot size trans-
verse resolution, with a corresponding confocal parameter of
approximately 442 m. The focus was placed approximately
300 m above the bottom surface of the flow-cell tube to
optimize visualization of features at both the bottom and top
surfaces. Image acquisition rates were 15 to 30 s, depending
on image size, and could be considerably faster 4 to 32 fps
using more sophisticated delay-line scanning mechanisms40,41
or spectral-domain OCT detection.42–44 Biofilms growing in
the flow cell were continuously imaged every 4 or 8 h for up
to 72 h.
2.3 Fluorescence Microscopy and Confocal Scanning
Laser Microscopy
Fluorescence microscopy and CSLM Model DM-IRE, Leica
Microsystems, Bensheim, Germany were used to acquire
fluorescent images of P. aeruginosa growing on the surface at
the bottom of the glass flow-cell tube. A wavelength of
488 nm was used to excite the GFP, and the 514-nm emission
wavelength was detected in the epidirection. Samples were
imaged in the sequential mode with 63 and 20 objectives.
May/June 2006  Vol. 1132
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3-D volumetric CSLM images were reconstructed from a se-
ries of 28 horizontal-sectional images spaced at 1-m sepa-
ration using commercial software Slicer Dicer, Pixotec, LLC,
Renton, Washington. 3-D volumetric OCT images were re-
constructed from a series of 128 cross sectional images
spaced at 15.5-m separation using commercial software
Slicer Dicer, Pixotec, LLC, Renton, Washington, or Amira,
Zuse Institute, Berlin, Germany. 2-D cross sectional OCT
images along the Y and Z axes were also obtained with the
same software.
3 Results
OCT, as an emerging high-resolution imaging technology, has
been widely applied in medical and biological research. To
test the potential of OCT in the study of biofilm structure and
function, we imaged a Pseudomonas aeruginosa PAO1 bio-
film using a time-domain OCT system similar to the one used
to image structure and fluid flow in microfluidic mixers.45
A 3-D image of the biofilm 72 h after inoculation devel-
oped on the inner surfaces of glass flow cell was reconstructed
and volume rendered using commercial software Amira,
Zuse Institute, Berlin, Germany Fig. 2a, which clearly
shows a complete biofilm developed in the tube. More de-
tailed visualization of structure inside the biofilm can be ob-
tained from 2-D sections of 3-D dataset at different planes
Figs. 2b–2d. Figure 2b shows a cross sectional OCT
image of the biofilm. Cell aggregates separated by interstitial
voids and water channels are clearly seen. The biofilm on the
top of the tube is flatter than the biofilm at the bottom. More
projections or “mushrooms” of bacterial aggregates are vis-
Fig. 2 OCT imaging of a 3-day P. aerogenosa biofilm in the glass
capillary of a biofilm flow cell. The dimension of the tube is 1
1 mm and the length of the visualized biofilm is 2 mm. a Volume-
rendered 3-D reconstruction of the biofilm from a series of 128 cross
sectional images. b Cross sectional OCT image of the biofilm shown
in a. c Vertical section of biofilm shown in a, along the length of
the tube. Bottom and top of the tube are indicated. Arrows indicate
projections or “mushrooms” in the biofilm at the bottom. d Horizon-
tal section of biofilm along the bottom. Scale bar represents 200 m.ible on the surface at the bottom of the tube than on the top.
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Twenty-four hours after inoculation, signals indicating cell
growth on the surface at the bottom of the glass capillary can
be observed, and more cells accumulate on the surfaces with
longer incubation time. Microcolonies are clearly seen two
days after inoculation. Biofilm structural features, including
interstitial voids, water channels, and “mushrooms” of bacte-
rial aggregates, are visible by three days after inoculation. On
the top of the glass tube, OCT signals indicate less biofilm
growth, compared to that at the bottom, and the biofilm sur-
face is relatively flatter.
We also developed a P. aeruginosa biofilm in a cuvette
see materials and methods and scanned a portion 2
2 mm of the biofilm Fig. 4. Different cell aggregates
were observed embedded in the likely heterogeneous density
of the extracellular polymer matrix. Voids spaces are clearly
observed Fig. 4a. A reconstructed 3-D image registers a
floating piece of biofilm as shown in Fig. 4b.
For comparison, fluorescence microscopy FM and CSLM
were used to image the early stages 0 to 48 h of P. aerugi-
nosa biofilm development at the bottom in these flow cells
Fig. 5. Detailed structures including initial sites of coloniza-
tion and spreading growth patterns are evident from FM and
CSLM. Structural features of P. aeruginosa biofilm develop-
ment at the bottom revealed by CSLM and OCT are visually
similar Figs. 2 and 5.
4 Discussions
The biofilm structural data obtained from OCT are visually
similar with data obtained from other imaging techniques.
Mathematical interpretation of the data and optical property
measurements of these biofilms obtained with OCT are cur-
rently underway and will provide additional information.
More interestingly, we were able to completely image with
high resolution the biofilms developed in the flow-cell tube to
a depth of about 2 mm as a result of the OCT imaging depth.
We were also able to scan large areas and 3-D volumes of
biofilms with high resolution. These data clearly demonstrated
that OCT is a novel and useful imaging technology to
characterize biofilm development dynamics under different
conditions.
The resolution of the OCT system used in this study was
Fig. 3 OCT imaging of biofilm growth. Sequential 2-D OCT images of
P. aerogenosa biofilm growth dynamics in the glass flow cell. Imaging
times are indicated above or below the corresponding figure. Biofilm
growth on the bottom of the flow cell includes multiple projections
indicated with open arrow and voids indicated with solid black
arrows. Scale bar represents 200 m.high 2.8-m axial, 15-m transverse. However, these reso-
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which may limit OCT for the application in bacterial adhesion
studies. FM and CSLM were used to image the earliest stages
of biofilm development for comparison purposes Fig. 5. De-
tailed structures shown with FM and CSLM imaging are evi-
dent, and structural features at later stages 48 h revealed by
CSLM and OCT look similar Figs. 2 and 5. While FM and
CSLM are able to identify single fluorescing bacteria and
small microcolonies, imaging of biofilms using FM and
CSLM requires that the microscope objective be in close
proximity to the biofilm surface, and is typically limited in the
depth of imaging penetration to less than one hundred mi-
crons. Submicron OCT imaging is feasible by incorporating
ultrabroad-bandwidth titanium:sapphire lasers,46,47 and the use
of these sophisticated laser systems may enable OCT to study
these earliest stages of biofilm development as well. Still, the
resolutions afforded by the OCT system in this study and
other state of the art systems enables the larger-scale imaging
of microbial colonies, and the microstructure that develops in
these biofilms. Further research is underway to expand the
resolution capabilities of our OCT systems, including the use
of optical coherence microscopy OCM.
Implementing other OCT-related techniques will further
improve the characterization of biofilm structure and function.
Flow dynamics will have significant effects on biofilm struc-
ture and function. OCT is not only capable of imaging 3-D
microstructures at micron-scale resolutions, but can also ob-
tain velocity profiles at real-time acquisition rates in small
lumens and vessels48–51 in a manner analogous to laser-
Doppler velocimetry or Doppler ultrasound. Doppler OCT has
been used in our previous studies to visualize fluid flow ve-
locity profiles in capillary tubes and microfluidic channels.45
Doppler OCT imaging can be used to provide quantitative
information on biofilm dynamics, flow velocities, and flow
distributions during the formation of biofilms within catheters
iofilm growth. Early stages of biofilm growth are shown at the bottom
ted GFP-labeled bacteria at 4 h, which develop into microcolonies
he lower right image is a volume-rendered 3-D reconstruction of the
m in the fluorescence micrographs and 50 m in the 3-D CSLMFig. 4 OCT imaging of an interfacial biofilm. A 3-day P. aeruginosa
biofilm developed at the interface of air and culturing media is shown.
The area scanned is 22 mm. a cross sectional OCT image of the
biofilm showing microbial cell aggregates and matrix. Arrows indicate
cell aggregates right and voids left. b 3-D reconstruction of the
biofilm showing uneven surfaces and detachment of cell aggregatesFig. 5 Fluorescence microscopy and confocal scanning laser microscopy of b
of the glass flow-cell tube. Time sequence over the initial 48 h shows isola
8 h and proliferate 16 to 48 h to form a thin relatively smooth surface. T
biofilm from a series of 16 en face CLSM sections. Scale bar represents 10May/June 2006  Vol. 1134
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ing contrast agents such as lipids or proteins or inert nanopar-
ticles for this purpose if the bacteria-laden fluids or nutrient-
rich media lack sufficient optical scattering properties.
Substrates and nutrient heterogeneity in biofilms will often
define biofilm structure and function. A technique called spec-
troscopic OCT or spectroscopic OCM SOCT/SOCM52–54 en-
ables high-resolution spatial localization of spectroscopic in-
formation from a sample, which can be used to identify and
characterize certain chemicals, absorbers, and scatterers. We
expect that spectroscopic OCT/OCM will enable the study of
substrate gradients and consumption dynamics in biofilms, as
well as enable the investigation of interaction dynamics be-
tween cells and substrates.
It is likely that OCT/OCM can differentiate cells and the
polymer matrix in biofilms, as the scattering properties of
cells and polymers differ. By setting a threshold of pixel in-
tensity within the OCT images, it may be possible to differ-
entiate cells and polymers so that biomass can be calculated
from each image, as shown in Fig. 3. This research is cur-
rently under investigation. In addition, the acquisition rates of
spectral-domain OCT now can reach 30 frames per second
or greater, depending on image size, making it possible to
acquire images of complete biofilm development in real time
and compute bacterial growth in biofilms in 3-D volumes in
real time. These quantitative data will be useful for math-
ematically modeling biofilm growth, as it will provide data of
a complete biofilm rather than a portion of a biofilm.
OCT has been used to image both in-situ and in-vivo tis-
sues and identify regions that suggest abnormalities that
should be biopsied for histopathological examination.55–57
OCT catheters have been developed for internal imaging of
tubular lumens, and an intravascular OCT imaging system
was recently developed for in-vivo intravascular imaging in
humans.58 We expect that catheter-based OCT systems will
permit in-situ imaging and analysis of biofilms developing on
medical tubing and hollow catheters such as endotrachial
tubes, vascular-access catheters, and urinary catheters. This
will enable the in-vivo characterization of biofilms developed
in clinical and natural environments. Similar OCT imaging
catheters will also permit visualization and investigation of
tubing and pipeworks in industrial systems.
By fully employing these existing capabilities of OCT,
there is a significant potential for OCT to be used as a nonin-
vasive, label-free, real-time, in-situ and/or in-vivo imaging
modality for biofilm characterization.
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